Recent research suggests that GLP-1 receptor agonistsmedications like Ozempic, Wegovy, and Zepboundmay increase the risk of iron deficiency anemia
Below you will find pitfalls in the diagnosis and treatment of B12 deficiency
In fact, she spends most of her time with patients discussing how to eat differently and providing them with healthy recipes
In June 2021, Huadong Medicine applied to the State Intellectual Property Office to invalidate Novo Nordisks patent for semaglutide in China, which was originally scheduled to expire in 2026
Adding a GLP-1 receptor agonist as a coadjutant therapy in the early post-transplant period to the appropriate patient brings good metabolic outcomes and also is safe, Mario Campana, MD, fellow in the division of endocrinology, diabetes and metabolism at the Heersink School of Medicine at the University of Alabama at Birmingham (UAB), told Healio